Skip to content

5-MeO-DMT: all studies

Page 55 of 110: studies 541 to 550 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

Elevated Endogenous Psychedelic Bufotenine in the Urine of Patients Diagnosed With a Mental Illness: A Systematic Review.

Cureus May 20, 2025 Alistair J Clarke 1 citation

The objective of this systematic review was to determine if higher concentrations of urinary bufotenine occur in patients with a mental illness compared to healthy controls. Bufotenine is an alkaloid with psychedelic and psychoactive properties that closely resembles the structure of serotonin. Bufotenine naturally occurs in Anadenanthera seeds and is secreted along with 5-methoxy-N,...

DOI: 10.7759/cureus.84510 (opens in new tab) Full text (opens in new tab) Bufotenine Natural psychedelic compound Mental illness Mental health diagnoses +13

Natural language analysis of the structure of altered states of consciousness

Journal of Psychedelic Studies May 17, 2025 Daria Dikovskaya, Bhargav Srinivasa Desikan, Joel Frohlich et al. 2 citations

Abstract Background and aims Altered states of consciousness (ASC) represent acute and marked deviations from normal waking consciousness. Investigations into ASC are significant to problems in medicine, science, and philosophy, including the structure of conscious experience. Here, we conducted a preliminary investigation into the structure of ASC while addressing the role of psychedelics,...

DOI: 10.1556/2054.2025.00441 (opens in new tab) Natural archaeology Consciousness Linguistics

Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.

Psychopharmacology May 17, 2025 Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland et al. 12 citations

The head twitch response (HTR) is a spontaneously occurring behavior in mice that is increased in frequency by serotonergic psychedelics. The mouse HTR is often used as a proxy for psychedelic-like drug effects, but limited information is available about sex differences in HTRs evoked by various classes of psychedelics (i.e., phenethylamines, lysergamides, tryptamines). To examine potential sex...

DOI: 10.1007/s00213-025-06795-x (opens in new tab) Full text (opens in new tab) 5-ht2a Head twitch response Mice Psychedelics hallucinogens +6

Pathway engineering for the biosynthesis of psychedelics

Current Opinion in Biotechnology May 15, 2025 Zachary N. Abrahms, Abhishek K. Sen, J. Andrew Jones 2 citations

Naturally occurring psychoactive compounds have been used for cultural and ethnomedical purposes for centuries. Several more such molecules continue to be chemically synthesized, exhibiting a wide range of potency, therapeutic, and hallucinogenic effects. Promising clinical data and a renewed interest in understanding the cellular mechanisms of action have inspired synthetic biology efforts to...

The Analysis of Hallucinogenic Drugs from Plants and Fungi

May 14, 2025 Michael D. Cole, Lata Gautam, Agatha Grela 1 citation

This chapter introduces drugs derived from plants and fungi including lysergic acid diethylamide (LSD), psilocybin (from ‘magic mushrooms’), N,N-dimethyltryptamine (DMT) and mescaline. Their physical description and chemical identification are described. The use of fluorescence detection for HPLC analysis of drugs and the greater selectivity it offers over UV and diode array detection are...

DOI: 10.1039/9781837673056-00062 (opens in new tab) Hallucinogen Traditional medicine

Ayahuasca reverses ischemic stroke-induced neuroinflammation and oxidative stress.

Behavioural Brain Research May 8, 2025 Larissa da Silva Joaquim, Lara Rodrigues da Rosa, Yasmin Strickert et al. 5 citations

Ischemic stroke is a leading cause of death and disability worldwide. Survivors face disability and psychiatric sequelae resulting from ischemia-induced cell death and associated neuroinflammation, and oxidative stress. Herbal medicines have been shown to elicit neuroprotective effects following stroke due to their anti-inflammatory and antioxidant effects. Preliminary evidence suggests that...

DOI: 10.1016/j.bbr.2025.115521 (opens in new tab) Full text (opens in new tab) DMT Ischemic stroke Neuroinflammation Neuroprotection +6

Exploring DMT: Endogenous role and therapeutic potential.

Neuropharmacology May 1, 2025 Jakub Schimmelpfennig, Kamila Jankowiak-Siuda 47 citations

N,N-Dimethyltryptamine (DMT) is a naturally occurring amine and psychedelic compound, found in plants, animals, and humans. While initial studies reported only trace amounts of DMT in mammalian brains, recent findings have identified alternative methylation pathways and DMT levels comparable to classical neurotransmitters in rodent brains, calling for a re-evaluation of its biological role and...

Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey

Journal of Psychedelic Studies April 22, 2025 Sophie van der Helder, Krista J. Siefried, Liam Acheson et al. 1 citation

Improved outcomes for substance use disorders have been described following non-clinical (“naturalistic”) psychedelic use. This exploratory study aimed to describe the naturalistic psychedelic experiences of people with substance use concerns and their reported needs and perceived utility of psychosocial support following naturalistic psychedelic use to integrate experiences and achieve...

Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress

Psychedelic Medicine April 22, 2025 Sean M. Viña 6 citations

Objective: Prior research has found an association between psychedelic use and reduced stigma attached to mental illness. However, whether psychedelics alleviate stigma-related distress remains unclear. Since stigma impacts different groups uniquely, any moderating effect of psychedelics on stigma-related distress is likely to vary across subpopulations. This study addresses two main questions:...

Speech markers of psychedelic-induced psychological change

bioRxiv April 21, 2025 Joanna Kuć, Rosalind McAlpine, Amelia Sellers et al. preprint

Abstract 5-MeO-DMT, a potent, short-acting psychedelic, induces profound shifts in cognition, affect, and self-awareness. Because language explicitly expresses these domains and voice implicitly conveys them, both may serve as potential ‘biomarkers’ of behavioural change. This study introduces a novel framework for analysing baseline language and vocal features, pre- to post-psychedelic...

DOI: 10.1101/2025.04.16.649217 (opens in new tab) Psychedelics Mental health Linguistics Cognitive science +1